J H P Wilson
Overview
Explore the profile of J H P Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biolcati G, Hanneken S, Minder E, Neumann N, Wilson J, Wolgen P, et al.
J Patient Rep Outcomes
. 2021 Aug;
5(1):73.
PMID: 34396462
No abstract available.
2.
Biolcati G, Hanneken S, Minder E, Neumann N, Wilson J, Wolgen P, et al.
J Patient Rep Outcomes
. 2021 Aug;
5(1):65.
PMID: 34342778
Background: A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the...
3.
Wensink D, Langendonk J, Overbey J, Balwani M, Van Broekhoven E, Wagenmakers M, et al.
Genet Med
. 2021 May;
23(9):1616-1623.
PMID: 33941881
Purpose: Patients with erythropoietic protoporphyria (EPP), a severe painful photodermatosis, experience prodromal sensations when exposed to sunlight, which are the "warning signals" to exit the sun, as prolonged exposure causes...
4.
Biewenga M, Matawlie R, Friesema E, Koole-Lesuis H, Langeveld M, Wilson J, et al.
Br J Dermatol
. 2017 Aug;
177(6):1693-1698.
PMID: 28815553
Background: Erythropoietic protoporphyria (EPP) is a rare metabolic disease with painful photosensitivity due to protoporphyrin IX accumulation. Objectives: To evaluate bone mineral density (BMD) and known osteoporosis risk factors in...
5.
Vroegindeweij L, van der Beek E, Boon A, Hoogendoorn M, Kievit J, Wilson J, et al.
Diabet Med
. 2015 Feb;
32(8):993-1000.
PMID: 25661792
Aim: To detect features that might lead to the early diagnosis and treatment of aceruloplasminemia, as initiation of treatment before the onset of neurological symptoms is likely to prevent neurological...
6.
Vroegindeweij L, Boon A, Wilson J, Langendonk J
J Inherit Metab Dis
. 2014 Nov;
38(2):375-6.
PMID: 25413956
No abstract available.
7.
Spelt J, de Rooij F, Wilson J, Zandbergen A
J Inherit Metab Dis
. 2013 Oct;
33 Suppl 3:S1-4.
PMID: 24137761
Background: The main symptom of patients with erythropoietic protoporphyria (EPP) is painful photosensitivity, starting within minutes of sun exposure and leading to sun-avoidance. As 80-100% of vitamin D is synthesized...
8.
de Rooij F, Kavelaars F, Koole-Lesuis H, Wilson J
Cell Mol Biol (Noisy-le-grand)
. 2009 Aug;
55(2):64-9.
PMID: 19656453
Introduction: Acute intermittent porphyria (AIP), the most common acute hepatic porphyria, is an autosomal dominant inborn disorder of heme biosynthesis caused by mutations in the porphobilinogen deaminase (PBGd) gene. The...
9.
van der Linde K, Boor P, Mejissen M, Sandkuijl L, Houwing-Duistermaat J, Kuipers E, et al.
Hepatogastroenterology
. 2007 Aug;
54(77):1467-71.
PMID: 17708278
Background/aims: The pathogenesis of inflammatory bowel disease is complex, multifactorial, and involves genetic predisposition. This predisposition is likely to include various chromosomal loci, but simple Mendelian inheritance cannot be excluded...
10.
Soliman O, Timmermans R, Nemes A, Vletter W, Wilson J, Ten Cate F, et al.
J Inherit Metab Dis
. 2007 Jun;
30(5):750-7.
PMID: 17574537
Background: Cardiac involvement in mucopolysaccharidosis type I (MPS I) has been studied primarily in its most severe forms. Cardiac involvement, particularly left ventricular (LV) systolic and diastolic function, in the...